Literature DB >> 8662111

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.

M Sasaki1, Y Ichiya, Y Kuwabara, Y Akashi, T Yoshida, T Fukumura, S Murayama, T Ishida, K Sugio, K Masuda.   

Abstract

We evaluated the usefulness of fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG PET) in the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer and then compared the findings with the results of X-ray CT by region based on the histological diagnoses. We examined 29 patients with non-small cell lung cancer. One hundred and thirty-two mediastinal lymph nodes were surgically removed and the histological diagnoses were confirmed. FDG PET images, including 146 mediastinal regions, were visually analysed and the mediastinal lymph nodes were scored as positive when the FDG uptake was higher than that in the other mediastinal structures. On the X-ray CT scans, any mediastinal lymph nodes with a diameter of 10 mm or larger were scored as positive. All three examinations were successfully performed on 71 regions. For FDG PET, we found a sensitivity of 76%, a specificity of 98% and an accuracy of 93%. On the other hand, for X-ray CT a sensitivity of 65%, a specificity of 87% and an accuracy of 82% were observed. A significant difference was observed in respect of both specificity and accuracy (P<0.05). Based on the above findings, FDG PET is suggested to be superior to X-ray CT when used for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662111     DOI: 10.1007/bf00843701

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  Differential diagnosis of lung tumor with positron emission tomography: a prospective study.

Authors:  K Kubota; T Matsuzawa; T Fujiwara; M Ito; J Hatazawa; K Ishiwata; R Iwata; T Ido
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

2.  Aggressive surgical intervention in N2 non-small cell cancer of the lung.

Authors:  Y Watanabe; J Shimizu; M Oda; Y Hayashi; S Watanabe; Y Tatsuzawa; T Iwa; M Suzuki; T Takashima
Journal:  Ann Thorac Surg       Date:  1991-02       Impact factor: 4.330

3.  Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.

Authors:  C A Staples; N L Müller; R R Miller; K G Evans; B Nelems
Journal:  Radiology       Date:  1988-05       Impact factor: 11.105

4.  Mediastinal lymph node metastases from bronchogenic carcinoma: detection with MR imaging and CT.

Authors:  P Y Poon; M J Bronskill; R M Henkelman; D F Rideout; H S Shulman; G L Weisbrod; M I Steinhardt; H J Dunlap; R J Ginsberg; R Feld
Journal:  Radiology       Date:  1987-03       Impact factor: 11.105

Review 5.  Lung cancer: update on staging classifications.

Authors:  P J Friedman
Journal:  AJR Am J Roentgenol       Date:  1988-02       Impact factor: 3.959

6.  Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.

Authors:  P J Lewis; A Salama
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

7.  Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.

Authors:  T C McLoud; P M Bourgouin; R W Greenberg; J P Kosiuk; P A Templeton; J A Shepard; E H Moore; J C Wain; D J Mathisen; H C Grillo
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

8.  A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection.

Authors:  P Som; H L Atkins; D Bandoypadhyay; J S Fowler; R R MacGregor; K Matsui; Z H Oster; D F Sacker; C Y Shiue; H Turner; C N Wan; A P Wolf; S V Zabinski
Journal:  J Nucl Med       Date:  1980-07       Impact factor: 10.057

9.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.

Authors:  S Yamada; K Kubota; R Kubota; T Ido; N Tamahashi
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

10.  Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.

Authors:  L H Brudin; S O Valind; C G Rhodes; C F Pantin; M Sweatman; T Jones; J M Hughes
Journal:  Eur J Nucl Med       Date:  1994-04
View more
  8 in total

Review 1.  18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

Authors:  G Laking; P Price
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  [Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].

Authors:  K Orino; M Kawamura; J Hatazawa; I Suzuki; Y Sazawa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

3.  Oncologic positron emission tomography: a surgical perspective.

Authors:  Todd O Moore; Landis K Griffeth
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

4.  Effectiveness of positron emission tomography for the detection of melanoma metastases.

Authors:  W D Holder; R L White; J H Zuger; E J Easton; F L Greene
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

Review 5.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

6.  Clinical application of positron emission tomography in designing radiation fields in non-small cell lung cancer patients.

Authors:  Alexander Lin; Charles Wood; Christine Hill-Kayser; Rosemarie Mick; Larry Kaiser; James Metz
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

Review 7.  Current role of positron emission tomography in thoracic oncology.

Authors:  V J Lowe; K S Naunheim
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

8.  Improving radiation therapy for non-small cell lung cancer: molecular imaging and a team-based approach.

Authors:  Sj Everitt; M Mac Manus
Journal:  Biomed Imaging Interv J       Date:  2007-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.